Retrieving the latest stories.
The most consequential developments in technology and the world, selected against strict editorial criteria. Each is explained in twenty seconds.
Why it mattersThe first Phase 3 result showing a personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% (82% vs 70% at two years) moves individualized cancer medicine from promise toward regulatory approval.
Why it mattersA binding eight-year residence pledge and economist estimates of negative net revenue change how the stock plan should be read.
Why it mattersFrance reported the first known human Shamonda virus infection, a livestock pathogen long thought non-transmissible to humans and now spreading across Europe's cattle, though causation is unconfirmed and the patient was severely immunosuppressed.
Why it mattersA 21% year-on-year drop in Q3 PC shipments, tied to RAM and chip cost inflation, ending two years of growth, leaves fewer affordable options for price-sensitive buyers and forecasts a further 27% fall in Q4, though it extends an already-reported memory-shorta…